Long non-coding RNA: A versatile regulator of the nuclear factor-κB signalling circuit

Immunology

Volumn 150, Issue 4, 2017, Pages 379-388

  Mao, Xiaohua ^a   Su, Zhenyi ^a   Mookhtiar, Adnan K ^b  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cancer; Inflammation; Long non coding RNA; Nuclear factor B signalling; Regulation

Indexed keywords

ARID2 PROTEIN; C2DAT1 PROTEIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CYCLOOXYGENASE 2; CYTOKINE; DEXAMETHASONE; DLEU1 PROTEIN; DLEU2 PROTEIN; ERNA PROTEIN; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON RECEPTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; LETHE PROTEIN; LONG UNTRANSLATED RNA; METHOTREXATE; MICRORNA; MIR31HG PROTEIN; PACER PROTEIN; PLATINUM; PROTEIN P21; RBT46 PROTEIN; REGULATOR PROTEIN; THRIL PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MALAT1; TRANSCRIPTION FACTOR NKILA; UNCLASSIFIED DRUG; UNINDEXED DRUG; UNTRANSLATED RNA;

ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNE DISEASE; CHEMOSENSITIVITY; COMPLEX FORMATION; FIBROBLAST; GENE EXPRESSION; GENE TARGETING; HISTOPATHOLOGY; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INNATE IMMUNITY; METASTASIS; MOLECULAR DYNAMICS; MOLECULE; MULTIPLE CANCER; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PSEUDOGENE; REVIEW; RNA TRANSLATION; SIGNAL TRANSDUCTION; ANIMAL; CELL TRANSFORMATION; GENE EXPRESSION REGULATION; GENE THERAPY; GENETICS; HOMEOSTASIS; IMMUNOLOGY; METABOLISM; MOLECULARLY TARGETED THERAPY; MOUSE;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION; GENETIC THERAPY; HOMEOSTASIS; HUMANS; INFLAMMATION; MICE; MOLECULAR TARGETED THERAPY; NF-KAPPA B; RNA, LONG NONCODING; SIGNAL TRANSDUCTION;

EID: 85010628715     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12698     Document Type: Review

References (60)

1. Hayden MS, Ghosh S. NF-κB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev 2012; 26:203-34.
2. Napetschnig J, Wu H. Molecular basis of NF-κB signaling. Ann Rev Biophy 2013; 42:443.
3. Lu T, Stark GR. NF-κB: regulation by methylation. Cancer Res 2015; 75:3692-5.
4. Gerondakis S, Fulford TS, Messina NL, Grumont RJ. NF-κB control of T cell development. Nat Immunol 2014; 15:15-25.
5. Hoesel B, Schmid JA. The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer 2013; 12:1.
6. Vallabhapurapu S, Karin M. Regulation and function of NF-κB transcription factors in the immune system. Annu Rev Immunol 2009; 27:693-733.
7. Razani B, Reichardt AD, Cheng G. Non-canonical NF-κB signaling activation and regulation: principles and perspectives. Immunol Rev 2011; 244:44-54.
8. Liu Q, Chen Y, Auger-Messier M, Molkentin JD. Interaction between NFjB and NFAT coordinates cardiac hypertrophy and pathological remodeling. Circ Res 2012; 110: 1077-86.
9. Shinzawa M, Konno H, Qin J, Akiyama N, Miyauchi M, Ohashi H et al. Catalytic subunits of the phosphatase calcineurin interact with NF-κB-inducing kinase (NIK) and attenuate NIK-dependent gene expression. Sci Rep 2015; 5:10758.
10. Hadweh P, Habelhah H, Kieff E, Mosialos G, Hatzivassiliou E. The PP4R1 subunit of protein phosphatase PP4 targets TRAF2 and TRAF6 to mediate inhibition of NF-κB activation. Cell Signal 2014; 26:2730-7.
11. Ruland J. Return to homeostasis: downregulation of NF-κB responses. Nat Immunol 2011; 12:709-14.
12. Ulitsky I, Bartel DP. lincRNAs: genomics, evolution, and mechanisms. Cell 2013; 154:26-46.
13. Johnsson P, Lipovich L, Grandér D, Morris KV. Evolutionary conservation of long noncoding RNAs; sequence, structure, function. Biochim Biophys Acta 2014; 1840:1063-71.
14. Paralkar VR, Taborda CC, Huang P, Yao Y, Kossenkov AV, Prasad R et al. Unlinking an lncRNA from its associated cis element. Mol Cell 2016; 62:104-10.
15. Engreitz JM, Haines JE, Perez EM, Munson G, Chen J, Kane M, et al.Local regulation of gene expression by lncRNA promoters, transcription and splicing. Nature 2016; 539:452-5.
16. Wang KC, Yang YW, Liu B, Sanyal A, Corces-Zimmerman R, Chen Y et al. A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature 2011; 472:120-4.
17. Huarte M. The emerging role of lncRNAs in cancer. Nat Med 2015; 21:1253-61.
18. Cheng HS, Njock M-S, Khyzha N, Dang LT, Fish JE. Noncoding RNAs regulate NF-κB signaling to modulate blood vessel inflammation. Front Genet 2014; 5:422.
19. Zhang Y, Cao X. Long noncoding RNAs in innate immunity. Cell Mol Immunol 2016; 13:138-47.
20. Heward JA, Lindsay MA. Long non-coding RNAs in the regulation of the immune response. Trends Immunol 2014; 35:408-19.
21. Hoellen F, Kelling K, Dittmer C, Diedrich K, Friedrich M, Thill M. Impact of cyclooxygenase-2 in breast cancer. Anticancer Res 2011; 31:4359-67.
22. Krawczyk M, Emerson BM. p50-associated COX-2 extragenic RNA (PACER) activates COX-2 gene expression by occluding repressive NF-κB complexes. Elife 2014; 3:e01776.
23. Pearson MJ, Philp AM, Heward JA, Roux BT, Walsh DA, Davis ET et al. Long intergenic noncoding RNAs mediate the human chondrocyte inflammatory response and are differentially expressed in osteoarthritis cartilage. Arthritis Rheumatol 2016; 68:845-56.
24. Carpenter S, Aiello D, Atianand MK, Ricci EP, Gandhi P, Hall LL et al. A long noncoding RNA mediates both activation and repression of immune response genes. Science 2013; 341:789-92.
25. Hu G, Gong A-Y, Wang Y, Ma S, Chen X, Chen J et al. LincRNA-Cox2 promotes late inflammatory gene transcription in macrophages through modulating SWI/SNFmediated chromatin remodeling. J Immunol 2016; 196:2799-808.
26. Rapicavoli NA, Qu K, Zhang J, Mikhail M, Laberge R-M, Chang HY. A mammalian pseudogene lncRNA at the interface of inflammation and anti-inflammatory therapeutics. Elife 2013; 2:e00762.
27. Duret L, Chureau C, Samain S, Weissenbach J, Avner P. The Xist RNA gene evolved in eutherians by pseudogenization of a protein-coding gene. Science 2006; 312:1653-5.
28. Xiong Y, Yuan J, Zhang C, Zhu Y, Kuang X, Lan L et al. The STAT3-regulated long noncoding RNA Lethe promote the HCV replication. Biomed Pharmacother 2015; 72:165-71.
29. Liu B, Sun L, Liu Q, Gong C, Yao Y, Lv X et al. A cytoplasmic NF-κB interacting long noncoding RNA blocks IjB phosphorylation and suppresses breast cancer metastasis. Cancer Cell 2015; 27:370-81.
30. Dijkstra JM, Alexander DB. The “NF-κB interacting long noncoding RNA”(NKILA) transcript is antisense to cancer-associated gene PMEPA1. F1000Res 2015; 4:96.
31. Gutschner T, Hämmerle M, Diederichs S. MALAT1—a paradigm for long noncoding RNA function in cancer. J Mol Med 2013; 91:791-801.
32. Zhao G, Su Z, Song D, Mao Y, Mao X. The long noncoding RNA MALAT1 regulates the lipopolysaccharide-induced inflammatory response through its interaction with NFjB. FEBS Lett 2016; 590:2884-95.
33. Li X, Zhu M, Brasier AR, Kudlicki AS. Inferring genome-wide functional modulatory network: a case study on NF-κB/RelA transcription factor. J Comput Biol 2015; 22:300-12.
34. West JA, Davis CP, Sunwoo H, Simon MD, Sadreyev RI, Wang PI et al. The long noncoding RNAs NEAT1 and MALAT 1 bind active chromatin sites. Mol Cell 2014; 55:791-802.
35. Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D et al. A large intergenic noncoding RNA induced by p 53 mediates global gene repression in the p53 response. Cell 2010; 142:409-19.
36. Dimitrova N, Zamudio JR, Jong RM, Soukup D, Resnick R, Sarma K et al. LincRNAp21 activates p21 in cis to promote Polycomb target gene expression and to enforce the G1/S checkpoint. Mol Cell 2014; 54:777-90.
37. Spurlock CF, Tossberg JT, Matlock BK, Olsen NJ, Aune TM. Methotrexate inhibits NFjB activity via long intergenic (noncoding) RNA-p21 induction. Arthritis Rheumatol 2014; 66:2947-57.
38. Özeş A, Miller D, özeş O, Fang F, Liu Y, Matei D et al. NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer. Oncogene 2016; 35:5350-61.
39. Wu H, Liu J, Li W, Liu G, Li Z. LncRNA-HOTAIR promotes TNF-a production in cardiomyocytes of LPS-induced sepsis mice by activating NF-κB pathway. Biochem Biophys Res Commun 2016; 471:240-6.
40. Rajbhandari R, McFarland BC, Patel A, Gerigk M, Gray GK, Fehling SC et al. Loss of tumor suppressive microRNA-31 enhances TRADD/NF-κB signaling in glioblastoma. Oncotarget 2015; 6:17805.
41. Jin C, Jia L, Huang Y, Zheng Y, Du N, Liu Y et al. Inhibition of lncRNA MIR31HG promotes osteogenic differentiation of human adipose-derived stem cells. Stem Cells 2016; 34:2707-20.
42. Xu Q, Deng F, Xing Z, Wu Z, Cen B, Xu S et al. Long non-coding RNA C2dat1 regulates CaMKIId expression to promote neuronal survival through the NF-κB signaling pathway following cerebral ischemia. Cell Death Dis 2016; 7:e2173.
43. Zhou Q, Chung AC, Huang XR, Dong Y, Yu X, Lan HY. Identification of novel long noncoding RNAs associated with TGF-b/Smad3-mediated renal inflammation and fibrosis by RNA sequencing. Am J Pathol 2014; 184:409-17.
44. Zhou Q, Huang XR, Yu J, Yu X, Lan HY. Long noncoding RNA Arid2-IR is a novel therapeutic target for renal inflammation. Mol Ther 2015; 23:1034-43.
45. Garding A, Bhattacharya N, Claus R, Ruppel M, Tschuch C, Filarsky K et al. Epigenetic upregulation of lncRNAs at 13q14. 3 in leukemia is linked to the in cis downregulation of a gene cluster that targets NF-κB. PLoS Genet 2013; 9:e1003373.
46. Ilott NE, Heward JA, Roux B, Tsitsiou E, Fenwick PS, Lenzi L et al. Long non-coding RNAs and enhancer RNAs regulate the lipopolysaccharide-induced inflammatory response in human monocytes. Nat Commun 2014; 5:3979.
47. Dinarello CA, van der Meer JW. Treating inflammation by blocking interleukin-1 in humans. Semin Immunol 2013; 25:469-84.
48. Chan J, Atianand M, Jiang Z, Carpenter S, Aiello D, Elling R et al. Cutting edge: a natural antisense transcript, AS-IL1a, controls inducible transcription of the proinflammatory cytokine IL-1a. J Immunol 2015; 195:1359-63.
49. Broadbent HM, Peden JF, Lorkowski S, Goel A, Ongen H, Green F et al. Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet 2008; 17:806-14.
50. Zhou X, Han X, Wittfeldt A, Sun J, Liu C, Wang X et al. Long non-coding RNA ANRIL regulates inflammatory responses as a novel component of NF-κB pathway. RNA Biol 2016; 13:98-108.
51. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010; 140:805-20.
52. Li Z, Chao T-C, Chang K-Y, Lin N, Patil VS, Shimizu C et al. The long noncoding RNA THRIL regulates TNFa expression through its interaction with hnRNPL. Proc Natl Acad Sci U S A 2014; 111:1002-7.
53. Tong Q, Gong A-Y, Zhang X-T, Lin C, Ma S, Chen J et al. LincRNA-Cox2 modulates TNF-a-induced transcription of Il12b gene in intestinal epithelial cells through regulation of Mi-2/NuRD-mediated epigenetic histone modifications. FASEB J 2016; 30: 1187-97.
54. Cui H, Xie N, Tan Z, Banerjee S, Thannickal VJ, Abraham E et al. The human long noncoding RNA lnc-IL7R regulates the inflammatory response. Eur J Immunol 2014; 44:2085-95.
55. Sun S-C, Chang J-H, Jin J. Regulation of nuclear factor-jB in autoimmunity. Trends Immunol 2013; 34:282-9.
56. Chery J, Näär A. RNA therapeutics: RNAi and antisense mechanisms and clinical applications. Postdoc J 2016; 4:35.
57. Zhou Y, Zhang C, Liang W. Development of RNAi technology for targeted therapy—a track of siRNA based agents to RNAi therapeutics. J Controlled Release 2014; 193: 270-81.
58. Hilton IB, D’Ippolito AM, Vockley CM, Thakore PI, Crawford GE, Reddy TE et al. Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat Biotechnol 2015; 33:510-7.
59. Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A et al. Landscape of transcription in human cells. Nature 2012; 489:101-8.
60. Mendell JT. Targeting a long noncoding RNA in breast cancer. N Engl J Med 2016; 374:2287-9.